COX-2 expression in adenoma: an imperfect marker for chemoprevention.
Chan
Andrew T
AT
Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. achan@partners.org
D000236:Adenoma / Q000201:enzymology* / Q000517:prevention & control; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000031:analogs & derivatives / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000517:prevention & control; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D006801:Humans; D008239:Lysine / Q000031:analogs & derivatives / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000201:enzymology / Q000517:prevention & control
D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor; D016861:Cyclooxygenase Inhibitors; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D008239:Lysine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate